Related references
Note: Only part of the references are listed.Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271
Walter Gregory Roberts et al.
CANCER RESEARCH (2008)
Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma
Jyotsnabaran Halder et al.
CANCER RESEARCH (2007)
Structural basis for the autoinhibition of focal adhesion kinase
Daniel Lietha et al.
CELL (2007)
A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth
Qing Shi et al.
MOLECULAR CARCINOGENESIS (2007)
Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo
Ta-Jen Liu et al.
MOLECULAR CANCER THERAPEUTICS (2007)
c-Src binds to the cancer drug imatinib with an inactive Abl/c-Kit conformation and a distributed thermodynamic penalty
Markus A. Seeliger et al.
STRUCTURE (2007)
Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.
T Bonome et al.
CANCER RESEARCH (2005)
Focal adhesion kinase: In command and control of cell motility
SK Mitra et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
PTC Wan et al.
CELL (2004)
Likelihood-enhanced fast rotation functions
LC Storoni et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
The structural basis for autoinhibition of FLT3 by the juxtamembrane domain
J Griffith et al.
MOLECULAR CELL (2004)
Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase
CD Mol et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Biological significance of focal adhesion kinase in ovarian cancer - Role in migration and invasion
AK Sood et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 1: Identification and optimisation of substituted 4,6-bis anilino pyrimidines
JF Beattie et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Structural basis for the autoinhibition of c-Abl tyrosine kinase
B Nagar et al.
CELL (2003)
FAK signaling in anaplastic astrocytoma and glioblastoma tumors
M Natarajan et al.
CANCER JOURNAL (2003)
The protein kinase complement of the human genome
G Manning et al.
SCIENCE (2002)
Structures of the cancer-related aurora-A, FAK, and EphA2 protein kinases from nanovolume crystallography
J Nowakowski et al.
STRUCTURE (2002)
Imatinib: a selective tyrosine kinase inhibitor
PW Manley et al.
EUROPEAN JOURNAL OF CANCER (2002)
The conformational plasticity of protein kinases
M Huse et al.
CELL (2002)
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
C Pargellis et al.
NATURE STRUCTURAL BIOLOGY (2002)
Share Paper
